MedicalSystem Biotechnology Co

MedicalSystem Biotechnology Co EBITDA per Share

The EBITDA per Share of MedicalSystem Biotechnology Co (300439.SZ) as of Oct 17, 2026 is 0.16 CNY. In the previous year, EBITDA per Share was 0.82 CNY — a change of -80.57% (lower).

EBITDA per Share

0.16CNY

YoY

-80.57%

Last updated:

EBITDA per Share of MedicalSystem Biotechnology Co is 2025 0.16 CNY. EBITDA per Share of MedicalSystem Biotechnology Co was 2024 0.82 CNY. It decreases by -80.57% lower compared to the previous year.

The MedicalSystem Biotechnology Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
1.13 CNY
Jan 1, 2019
-1.36 CNY
Jan 1, 2020
0.80 CNY
Jan 1, 2021
0.73 CNY
Jan 1, 2022
0.74 CNY
Jan 1, 2023
0.87 CNY
Jan 1, 2024
0.82 CNY
Jan 1, 2025
0.16 CNY
The MedicalSystem Biotechnology Co EBITDA per Share history
YEAREBITDA per ShareYoY
0.16CNY-80.57%
0.82CNY-5.87%
0.87CNY+18.53%
0.74CNY+1.54%
0.73CNY-9.61%
0.80CNY-159.14%
-1.36CNY-220.64%
1.13CNY-2.21%
1.15CNY+66.42%
0.69CNY+30.23%
0.53CNY-21.10%
0.67CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedicalSystem Biotechnology Co Stock analysis

What does MedicalSystem Biotechnology Co do? MedicalSystem Biotechnology Co Ltd is a biotechnology company based in Ningbo, China, operating within the healthcare sector. The company focuses on the research, development, and manufacturing of bio-tech pharmaceutical products. It employs 2,473 full-time staff and completed its initial public offering (IPO) on April 22, 2015. MedicalSystem Biotechnology offers in-vitro diagnostic products, including reagents and instruments, and provides third-party medical diagnosis services. The company also produces and distributes reagent raw materials. Its primary market is domestic, with operations concentrated within China. The company's headquarters are located in Ningbo, Zhejiang Province. MedicalSystem Biotechnology's website is https://www.nbmksw.com/. The company's business activities include the development and production of diagnostic products, alongside the provision of related medical services. It operates as a public company listed on the Shenzhen Stock Exchange under the ticker symbol 300439.SZ and is identified by the ISIN CNE100001Z25. The company's operations are centered on the domestic Chinese market, with no indication of significant international presence. MedicalSystem Biotechnology is engaged in the production of pharmaceuticals and diagnostic tools, serving healthcare providers and institutions within China. MedicalSystem Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedicalSystem Biotechnology Co stock

EBITDA per Share of MedicalSystem Biotechnology Co is 0.16 CNY in 2025.

EBITDA per Share of MedicalSystem Biotechnology Co changed from 0.82 CNY to 0.16 CNY, representing a -80.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share MedicalSystem Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MedicalSystem Biotechnology Co

All Key Metrics — MedicalSystem Biotechnology Co